Singapore, Singapore · Founded 2016 · Privately Held (backing)
Developer of an immune profiling system and analytical tools designed to support immunotherapy clinical development. ImmunoScape is based in Singapore, Singapore and was founded in 2016. Its last reported valuation was $80.8 million in Jun 2025. It has raised $60.4 million.
Last reported valuation
$80.8M
Oct 2026
Priced at
—
Total raised
$60.4M
Last round
—
Team — not yet on record
No current team members for ImmunoScape are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ImmunoScape with a free account
·Watch ImmunoScape: the Monday email on marks, rounds and moves
